These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35505674)

  • 1. Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.
    Butt OH; Zhou AY; Huang J; Leidig WA; Silberstein AE; Chheda MG; Johanns TM; Ansstas G; Liu J; Talcott G; Nakiwala R; Shimony JS; Kim AH; Leuthardt EC; Tran DD; Campian JL
    Neurooncol Adv; 2022; 4(1):vdac042. PubMed ID: 35505674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum: This is a corrigendum to: Kumthekar et al, A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac123, https://doi.org/10.1093/noajnl/vdac123.
    Neurooncol Adv; 2023; 5(1):vdad103. PubMed ID: 37664526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes in patients with recurrent glioblastoma treated with Laser Interstitial Thermal Therapy (LITT): A systematic review.
    Montemurro N; Anania Y; Cagnazzo F; Perrini P
    Clin Neurol Neurosurg; 2020 Aug; 195():105942. PubMed ID: 32470780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to: Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields.
    Neurooncol Adv; 2022; 4(1):vdac164. PubMed ID: 36325375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial.
    Song AJ; Ding K; Alnahhas I; Laperriere NJ; Perry J; Mason WP; Winch C; O'Callaghan CJ; Menten JJ; Brandes AA; Phillips C; Fay MF; Nishikawa R; Osoba D; Cairncross JG; Roa W; Wick W; Shi W
    Neurooncol Adv; 2022; 4(1):vdac011. PubMed ID: 35098127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to: Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study.
    Neurooncol Adv; 2023; 5(1):vdad155. PubMed ID: 38077211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma.
    Thomas JG; Rao G; Kew Y; Prabhu SS
    Neurosurg Focus; 2016 Oct; 41(4):E12. PubMed ID: 27690657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction to: Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature.
    Neurooncol Adv; 2024; 6(1):vdae116. PubMed ID: 38978962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma.
    Nasir A; Cardall A; Othman RT; Nicolaou N; Lourdusamy A; Linke F; Onion D; Ryzhova M; Cameron H; Valente C; Ritchie A; Korshunov A; Pfister SM; Grabowska AM; Kerr ID; Coyle B
    Neurooncol Adv; 2021; 3(1):vdab155. PubMed ID: 34988447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to: Epigenetic dysregulation in meningiomas.
    Neurooncol Adv; 2023; 5(1):vdac190. PubMed ID: 36632569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to: Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies.
    Neurooncol Adv; 2023; 5(1):vdad019. PubMed ID: 36923271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to: Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma.
    Neurooncol Adv; 2023; 5(1):vdad072. PubMed ID: 37303863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to: Surgery versus radiosurgery for vestibular schwannoma: Shared decision making in a multidisciplinary clinic.
    Neurooncol Adv; 2024; 6(1):vdae011. PubMed ID: 38312229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum to: Targeting the TREM1-positive myeloid microenvironment in glioblastoma.
    Neurooncol Adv; 2023; 5(1):vdac189. PubMed ID: 36632568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to: Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.
    Neurooncol Adv; 2023; 5(1):vdad114. PubMed ID: 37750101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis.
    Alnahhas I; Alsawas M; Rayi A; Palmer JD; Raval R; Ong S; Giglio P; Murad MH; Puduvalli V
    Neurooncol Adv; 2021; 3(1):vdab095. PubMed ID: 34258581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to: The long non-coding RNA
    Neurooncol Adv; 2023; 5(1):vdad051. PubMed ID: 37152807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum to: Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 1 newly diagnosed disease.
    Taslimi S; Ye VC; Zadeh G
    Neurooncol Adv; 2021; 3(1):vdab117. PubMed ID: 34485909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum to: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis.
    Neurooncol Adv; 2022; 4(1):vdac125. PubMed ID: 35958979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors.
    Wright J; Chugh J; Wright CH; Alonso F; Hdeib A; Gittleman H; Barnholtz-Sloan J; Sloan AE
    Neurosurg Focus; 2016 Oct; 41(4):E14. PubMed ID: 27690658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.